Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 24-hour intraocular pressure effects of brinzolamide/timolol versus brimonidine/timolol in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine/Timolol (brimonidine/timolol)
  • Brinzolamide/Timolol (brinzolamide/timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED